Donna Young

                   

Back to (Home) School

janne.cc     09-Aug-2008          

Planning the School Year - 2008/09 I spent all of last weekend and most of the preceding week planning out this school year so we could start on Monday…which we did. Before I mention anything else though, I MUST give some linky...                    

comments

GSK Pays $15M Milestone Tolerx Seeks to Change Diabetes Treatment with Otelixizumab

pharmiweb.co.uk     08-Aug-2008          

GSK Pays $15M Milestone Tolerx Seeks to Change Diabetes Treatment with Otelixizumab. BIOWORLD Today - Aug. 08, 2008 Byline: Donna Young, Washington Editor Cambridge, Mass.-based Tolerx Inc. is wagering that its experimental...                    

comments

Planning, planning, planning!

ru.wordpress.com     04-Aug-2008          

As the school year fast approaches, I have been trying to get all my ducks in row organizationally. Since K will be in high school this year (can I just say YIKES! one more time?) I feel the need to keep better records. M is...                    

comments

Elan Tanks on Mixed Results, Safety Concerns for AD Drug

pharmiweb.co.uk     31-Jul-2008   78 related          

Donna Young, Washington Editor Released : Wednesday, July 30, 2008 7:52 PM Investors reacted negatively Wednesday to full results of a 234-patient Phase II trial of Elan Corp. plc's bapineuzumab (AAB-001) that showed the drug...                    

comments

                   

Golf Notes: DiLeo shows what the JGA can produce

app.com     31-Jul-2008          

Pat DiLeo began competing in Junior Golf America, the tour his father, Chuck, founded in an effort to provide weekly tournaments for junior golfers throughout out the region from spring through early fall, when he was just nine...                    

comments

                   

Roche $43.7B Genentech Offer Likely to Feel Upward Pressure

pharmiweb.co.uk     22-Jul-2008   79 related          

Donna Young, Washington Editor Released : Monday, July 21, 2008 7:41 PM Roche Holding AG has offered $43.7 billion, or $89 per share, to buy the 44 percent it does not own already of Genentech Inc., the world's largest biotech....                    

comments

                   

ViroPharma to Acquire Lev Paying $443M Up Front

pharmiweb.co.uk     16-Jul-2008   55 related          

Donna Young, Washington Editor Released : Tuesday, July 15, 2008 8:07 PM Antibiotic maker ViroPharma Inc. is acquiring Lev Pharmaceuticals Inc. for $442.9 million up front, or $2.75 per share. Under the deal, ViroPharma gains...                    

comments

                   

Amgen Issues Positive Results; Settles Ortho Case for $200M

pharmiweb.co.uk     15-Jul-2008   54 related          

Donna Young, Washington Editor Released : Monday, July 14, 2008 8:26 PM At the market's open Monday, Amgen Inc. had some good news about denosumab, some negative news about an antitrust settlement, but also some faulty news...                    

comments

                   

FDA to Seek Black Box on All Epilepsy Drugs

pharmiweb.co.uk     09-Jul-2008   175 related          

Donna Young, Washington Editor Released : Tuesday, July 08, 2008 8:04 PM The FDA said in briefing documents that it will seek a black-box warning on all antiepileptic drugs, including Frazer, Pa.-based Cephalon Inc.'s Gabitril...                    

comments

                   

FDA Panel Calls for Cardio Studies for Diabetes Drugs

pharmiweb.co.uk     03-Jul-2008   101 related          

Donna Young, Washington Editor Released : Wednesday, July 02, 2008 8:40 PM SILVER SPRING, Md. - Companies investigating new drugs and biologics to treat diabetes should be required to routinely conduct additional preapproval...                    

comments

1 2 3 4 next »